TrialRespirology (Carlton, Vic.)2022

Effect of chronic mucus hypersecretion on treatment responses to inhaled therapies in patients with chronic obstructive pulmonary disease: Post hoc analysis of the IMPACT trial.

Philip J Thompson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.